ACADIA Pharmaceuticals reported a GAAP loss of $124.776 million for 9M 2021, down 41.9% from $214.824 million in the previous year. Revenue increased 10.2% to $353.387 million from $320.748 million a year earlier.
ACADIA Pharmaceuticals reported a GAAP loss of $124.776 million for 9M 2021, down 41.9% from $214.824 million in the previous year. Revenue increased 10.2% to $353.387 million from $320.748 million a year earlier. 
ir.acadia-pharm.com
English (US) 